Amylyx Pharmaceuticals (AMLX) Tax Rate (2022 - 2025)
Amylyx Pharmaceuticals' (AMLX) quarterly Tax Rate came in at 0.14% in Q4 2025, down 16695.0% year-on-year from N/an in Q4 2024, and down 100.08% quarter-over-quarter from 166.81% in Q4 2024.
Amylyx Pharmaceuticals (AMLX) Tax Rate (2022 - 2025) Analysis & Trends
Amylyx Pharmaceuticals' Tax Rate history runs 4 years deep, the most recent figure standing at 0.14% for Q4 2025.
- On a quarterly basis, Tax Rate fell 16695.0% year-over-year to 0.14% in Q4 2025; TTM through Dec 2025 was 0.03%, a 2103.0% decrease from a year earlier, with the FY2025 full-year figure at 0.03%, down 2103.0% from the prior year.
- Tax Rate fell to 0.14% in Q4 2025 per AMLX's latest filing, from 166.81% in the prior quarter.
- Across five years, Tax Rate topped out at 166.81% in Q4 2024 and bottomed at 12.12% in Q1 2023.
- The 4-year median for Tax Rate is 0.14% (2025), against an average of 18.79%.
- Across the five-year window, Tax Rate soared 12753 bps in 2024 and sank 16695 bps in 2025, its largest moves.
- Year by year, Tax Rate stood at 1.34% in 2022, then jumped by 3033 bps to 39.28% in 2023, then jumped by 325 bps to 166.81% in 2024, then tumbled by 100 bps to 0.14% in 2025.
- Per Business Quant, the three latest AMLX Tax Rate figures stand at 0.14% (Q4 2025), 166.81% (Q4 2024), and 0.2% (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 15.33 |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 20.71 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -23.33 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 13.63 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 171.33 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 19.81 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 34.48 |
| 10 | Amylyx Pharmaceuticals | 2.01 Bn | 2.01 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.14% |
| Dec 31, 2025 | -0.14% |
| Dec 31, 2025 | -0.14% |
| Dec 31, 2024 | 166.81% |
| Dec 31, 2024 | 166.81% |
| Dec 31, 2024 | 166.81% |
| Mar 31, 2024 | -0.20% |
| Mar 31, 2024 | -0.20% |
| Mar 31, 2024 | -0.20% |
| Dec 31, 2023 | 39.28% |
| Dec 31, 2023 | 39.28% |
| Dec 31, 2023 | 39.28% |
| Sep 30, 2023 | 6.77% |
| Sep 30, 2023 | 6.77% |
| Sep 30, 2023 | 6.77% |
| Jun 30, 2023 | 8.05% |
| Jun 30, 2023 | 8.05% |
| Jun 30, 2023 | 8.05% |
| Mar 31, 2023 | -12.12% |
| Mar 31, 2023 | -12.12% |